Overview

India IVF Services Market is poised to value over USD 1.3 billion by 2027 end at a CAGR of over 14.5% during the forecast period 2020 to 2027.

FutureWise Market Research has instantiated a report that provides an intricate analysis of India IVF Services Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the India IVF Services Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the India IVF Services Market:
• Sun Pharmaceuticals Industries Ltd.
• Lab IVF Asia Pte. Ltd.
• LG Life Sciences
• Cadila Pharmaceuticals Ltd.
• Bourn Hall Clinic
• Morpheus Life Sciences Pvt. Ltd.
• Southend Fertility and IVF Centre
• Nova IVI Fertility
• Bloom Fertility Center
• Manipalankur Andrology and Reproductive Medicine
• Cloudnine Hospitals
• Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.)
• Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.)
• Manipal fertility hospital
• MilannoThe Fertility Center
 (Note: The list of the major players will be updated with the latest market scenario and trends)

India IVF Services Market Segmentation:
By Gender
• Male
• Female
• Other (Combined)

By Procedure
• ICSI IVF
• Non-ICSI IVF
• IUI

By Cycle Type
• Fresh IVF Cycles
• Thawed IVF Cycles
• Donor Egg IVF Cycles

By Offering
• IVF Drugs
• IVF Media & Reagents
• IVF and IUI Services

By End User
• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the India IVF Services Market By Gender, By Procedure, By Cycle Type, By Offering and By End User.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— India
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. India IVF Services Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of India IVF Services Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. India IVF Services Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. India IVF Services Market, By Gender Historical Analysis and Forecast 2020-2027 (USD Million)
  7.1. Male
  7.2. Female
  7.3. Other (Combined)

8. India IVF Services Market, By Procedure Historical Analysis and Forecast 2020-2027 (USD Million)
  8.1. ICSI IVF
  8.2. Non-ICSI IVF
  8.3. IUI

9. India IVF Services Market, By Cycle Type Historical Analysis and Forecast 2020-2027 (USD Million)
  9.1. Fresh IVF Cycles
  9.2. Thawed IVF Cycles
  9.3. Donor Egg IVF Cycles

10. India IVF Services Market, By Offering Historical Analysis and Forecast 2020-2027 (USD Million)
  10.1. IVF Drugs
  10.2. IVF Media & Reagents
  10.3. IVF and IUI Services

11. India IVF Services Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
  11.1. Fertility Clinics
  11.2. Hospitals
  11.3. Surgical Centers
  11.4. Clinical Research Institutes

12. Market Share Analysis and Competitive Landscape  
   12.1. India Landscape - Key Players, Revenue and Presence
   12.2. India Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   12.3. India Emerging Companies
   12.4. India - Market Share Analysis and Key Regional Players
   12.5. India Key Player - Growth Matrix

13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   13.1. Sun Pharmaceuticals Industries Ltd.
         13.1.1. Company Overview
         13.1.2. Product Portfolio
         13.1.3. SWOT Analysis
         13.1.4. Financial Overview
         13.1.5. Strategic Overview
   13.2. Lab IVF Asia Pte. Ltd.
         13.2.1. Company Overview
         13.2.2. Product Portfolio
         13.2.3. SWOT Analysis
         13.2.4. Financial Overview
         13.2.5. Strategic Overview
   13.3. LG Life Sciences
         13.3.1. Company Overview
         13.3.2. Product Portfolio
         13.3.3. SWOT Analysis
         13.3.4. Financial Overview
         13.3.5. Strategic Overview
   13.4. Cadila Pharmaceuticals Ltd.
         13.4.1. Company Overview
         13.4.2. Product Portfolio
         13.4.3. SWOT Analysis
         13.4.4. Financial Overview
         13.4.5. Strategic Overview
   13.5. Bourn Hall Clinic
         13.5.1. Company Overview
         13.5.2. Product Portfolio
         13.5.3. SWOT Analysis
         13.5.4. Financial Overview
         13.5.5. Strategic Overview          
   13.6. Morpheus Life Sciences Pvt. Ltd.
         13.6.1. Company Overview
         13.6.2. Product Portfolio
         13.6.3. SWOT Analysis
         13.6.4. Financial Overview
         13.6.5. Strategic Overview      
   13.7. Southend Fertility and IVF Centre
         13.7.1. Company Overview
         13.7.2. Product Portfolio
         13.7.3. SWOT Analysis
         13.7.4. Financial Overview
         13.7.5. Strategic Overview
   13.8. Nova IVI Fertility
         13.8.1. Company Overview
         13.8.2. Product Portfolio
         13.8.3. SWOT Analysis
         13.8.4. Financial Overview
         13.8.5. Strategic Overview
   13.9. Bloom Fertility Center
         13.9.1. Company Overview
         13.9.2. Product Portfolio
         13.9.3. SWOT Analysis
         13.9.4. Financial Overview
         13.9.5. Strategic Overview
   13.10.Manipalankur Andrology and Reproductive Medicine
         13.10.1. Company Overview
         13.10.2. Product Portfolio
         13.10.3. SWOT Analysis
         13.10.4. Financial Overview
         13.10.5. Strategic Overview
   13.11.Cloudnine Hospitals
         13.11.1. Company Overview
         13.11.2. Product Portfolio
         13.11.3. SWOT Analysis
         13.11.4. Financial Overview
         13.11.5. Strategic Overview
   13.12.Gunasheela Hospital Mathrutva Fertility Centre (A Unit Of Max HealthCare Pvt. Ltd.)
         13.12.1. Company Overview
         13.12.2. Product Portfolio
         13.12.3. SWOT Analysis
         13.12.4. Financial Overview
         13.12.5. Strategic Overview
   13.13.Oasis Center (a unit of the entity Sadguru Healthcare Services Pvt. Ltd.)
         13.13.1. Company Overview
         13.13.2. Product Portfolio
         13.13.3. SWOT Analysis
         13.13.4. Financial Overview
         13.13.5. Strategic Overview
   13.14.Manipal fertility hospital
         13.14.1. Company Overview
         13.14.2. Product Portfolio
         13.14.3. SWOT Analysis
         13.14.4. Financial Overview
         13.14.5. Strategic Overview
   13.15.MilannoThe Fertility Center
         13.15.1. Company Overview
         13.15.2. Product Portfolio
         13.15.3. SWOT Analysis
         13.15.4. Financial Overview
         13.15.5. Strategic Overview        

14. Pre and Post COVID-19 Impact
   14.1. Positive influence on the healthcare industry
   14.2. The financial disruption of the manufacturing sector
   14.3. Impact of COVID-19 on emerging companies
   14.4. Significant mandates in the healthcare regulations initiated by administrations
   14.5. The overall economic slowdown of the developing and developed nations

15. FutureWise SME Key Takeaway Points for Client

Tables

Figures